{"id":"W3212329417","doi":"10.1016/j.hroo.2021.11.005","title":"Dose-limiting, adverse event–associated bradycardia with β-blocker treatment of atrial fibrillation in the GENETIC-AF trial","year":2021,"lang":"en","type":"article","venue":"Heart Rhythm O2","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Heart Institute; Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Bradycardia; Medicine; Metoprolol; Atrial fibrillation; Cardiology; Internal medicine; Heart rate; Sinus bradycardia; Beta blocker; Anesthesia; Heart failure; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":{"n_in":0,"stratum":"aff_core","weight":5595.2375,"opus":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Post hoc analysis of bradycardia during beta-blocker treatment in the GENETIC-AF trial; uses trial data to answer a clinical question."},"gpt":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"The analysis concerns adverse events and dosing in a clinical trial."},"grok":{"tier":"OUT","genre":"empirical","about_ca":false,"confidence":"high","reason":"Clinical cardiology analysis of bradycardia under beta-blockers in an AF trial."}}}